Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Steps in Outbreak Investigation01:18

Steps in Outbreak Investigation

425
In the ever-evolving field of public health, statistical analysis serves as a cornerstone for understanding and managing disease outbreaks. By leveraging various statistical tools, health professionals can predict potential outbreaks, analyze ongoing situations, and devise effective responses to mitigate impact. For that to happen, there are a few possible stages of the analysis:
425
Infection01:20

Infection

11.4K
When a pathogen enters the body and reproduces, it can cause an infection, damage body cells, and cause illness symptoms that eventually lead to disease. Therefore, its prevention requires breaking the chain of infection.
The chain begins with pathogens: bacteria, viruses, fungi, prions, or parasites such as protozoa helminths. These can be present on the skin as transient or resident flora, or they can be acquired from the environment. Identifying and treating the type of infection and...
11.4K
Causality in Epidemiology01:21

Causality in Epidemiology

1.4K
Causality or causation is a fundamental concept in epidemiology, vital for understanding the relationships between various factors and health outcomes. Despite its importance, there's no single, universally accepted definition of causality within the discipline. Drawing from a systematic review, causality in epidemiology encompasses several definitions, including production, necessary and sufficient, sufficient-component, counterfactual, and probabilistic models. Each has its strengths and...
1.4K
Defense Mechanism Against Infection01:26

Defense Mechanism Against Infection

9.0K
Natural flora, body system defenses, and inflammation are natural barriers of the body against infectious agents regardless of previous exposure. Normal floras of the human body refer to the microbial population that colonizes the skin and mucous membranes.
In addition, many body organ systems have unique defenses against infection. The skin is an intact, multilayered surface preventing invasion by microorganisms unless impaired. Mucous membranes lining the mouth, nose, and eyelids are barriers...
9.0K
Defense Against Bacterial Pathogens01:31

Defense Against Bacterial Pathogens

2.5K
The human immune system is a complex network of cells, tissues, and organs that work together to defend the body against bacterial infections. It consists of various immune cells, each playing a specific role in the defense mechanism.
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
2.5K
Principles of Disease Surveillance01:26

Principles of Disease Surveillance

405
Disease surveillance is the systematic collection, analysis, and interpretation of health data essential to the planning, implementation, and evaluation of public health practice. This process integrates data dissemination to entities responsible for preventing and controlling disease, injury, and disability. Surveillance systems provide crucial information for action, helping public health authorities make informed decisions to manage and prevent outbreaks, ensure public safety, optimize...
405

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

An open-label, long-term extension, multicenter study to evaluate the safety and efficacy of venlafaxine extended release in Japanese outpatients with generalized anxiety disorder.

PCN reports : psychiatry and clinical neurosciences·2026
Same authorSame journal

Revisiting nursing- and healthcare-associated pneumonia in Japan: Microbiology, multidrug resistance, and clinical outcomes compared with community-acquired pneumonia.

Respiratory investigation·2026
Same author

Clinical Factors Associated With Non-Completion of Durvalumab Maintenance Therapy After Chemoradiotherapy in Patients With Locally Advanced Non-Small Cell Lung Cancer: A Single-Center Retrospective Study.

Thoracic cancer·2026
Same author

Sarcomatoid Transformation of Pulmonary Mucinous Adenocarcinoma as a Mechanism of Immunotherapy Resistance.

Thoracic cancer·2026
Same author

Clinical characteristics of autoantibodies neutralizing type I interferons in patients with coronavirus disease 2019 across phases of severe acute respiratory syndrome coronavirus 2 circulation.

Respiratory investigation·2026
Same author

Pharmacological treatment of schizophrenia: Japanese Expert Consensus 2025.

Schizophrenia (Heidelberg, Germany)·2026

Related Experiment Video

Updated: Dec 23, 2025

Author Spotlight: Advancements in Multiplex Detection of Respiratory Viruses
03:53

Author Spotlight: Advancements in Multiplex Detection of Respiratory Viruses

Published on: November 10, 2023

1.7K

COVID-19 outbreak: An elusive enemy.

Toshiaki Kikuchi1

  • 1Department of Respiratory Medicine and Infectious Diseases, Niigata University Graduate School of Medical and Dental Sciences, Niigata 951-8510, Japan.

Respiratory Investigation
|April 28, 2020
PubMed
Summary

A novel coronavirus, severe acute respiratory syndrome (SARS)-CoV-2, caused the COVID-19 epidemic. Accelerated development of diagnostics, vaccines, and therapeutics is crucial due to potential asymptomatic transmission and severe disease cases.

Keywords:
COVID-19CoronavirusSARS-CoV-2

More Related Videos

Quantification and Whole Genome Characterization of SARS-CoV-2 RNA in Wastewater and Air Samples
09:26

Quantification and Whole Genome Characterization of SARS-CoV-2 RNA in Wastewater and Air Samples

Published on: June 30, 2023

1.5K
Production of a SARS-CoV-2 Virus-Like-Particle System to Investigate Viral Life Cycles In Vitro
09:26

Production of a SARS-CoV-2 Virus-Like-Particle System to Investigate Viral Life Cycles In Vitro

Published on: June 6, 2025

954

Related Experiment Videos

Last Updated: Dec 23, 2025

Author Spotlight: Advancements in Multiplex Detection of Respiratory Viruses
03:53

Author Spotlight: Advancements in Multiplex Detection of Respiratory Viruses

Published on: November 10, 2023

1.7K
Quantification and Whole Genome Characterization of SARS-CoV-2 RNA in Wastewater and Air Samples
09:26

Quantification and Whole Genome Characterization of SARS-CoV-2 RNA in Wastewater and Air Samples

Published on: June 30, 2023

1.5K
Production of a SARS-CoV-2 Virus-Like-Particle System to Investigate Viral Life Cycles In Vitro
09:26

Production of a SARS-CoV-2 Virus-Like-Particle System to Investigate Viral Life Cycles In Vitro

Published on: June 6, 2025

954

Area of Science:

  • Virology
  • Epidemiology

Background:

  • Severe acute respiratory syndrome (SARS)-CoV-2, a novel Betacoronavirus linked to bat coronaviruses, emerged in late 2019.
  • COVID-19, the resulting disease, rapidly spread globally, with over 100,000 cases reported within four months.
  • Genetic analysis confirms SARS-CoV-2 as a distinct Betacoronavirus strain.

Discussion:

  • Approximately 10% of COVID-19 patients experience severe illness requiring intensive care.
  • Asymptomatic transmission is a significant factor complicating outbreak containment efforts.
  • The rapid global spread highlights the urgent need for effective public health interventions.

Key Insights:

  • SARS-CoV-2 is genetically related to bat-derived coronaviruses.
  • A substantial proportion of COVID-19 cases progress to severe disease.
  • Asymptomatic carriers pose a challenge to controlling the epidemic.

Outlook:

  • Urgent development of rapid point-of-care diagnostic tests is essential.
  • Accelerated research into effective vaccines is critical for long-term control.
  • Therapeutic strategies must be rapidly advanced to manage severe COVID-19 cases.